Eli Lilly (LLY) Free Cash Flow (2009 - 2026)

Eli Lilly has reported Free Cash Flow for 18 years, with the latest figure at $3.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 1827.56% year-over-year to $3.0 billion; the trailing twelve-month figure through Mar 2026 stood at $11.8 billion (up 216.44% YoY), and the FY2025 full-year result was $9.0 billion, up 138.62% from the prior year.
• Free Cash Flow for Q1 2026 stood at $3.0 billion, up from $677.9 million in the prior quarter.
• The five-year high for Free Cash Flow was $6.7 billion in Q3 2025, with the low at -$1.4 billion in Q4 2023.
• Historically, Free Cash Flow has averaged $1.3 billion across 5 years, with a median of $1.1 billion in 2023.
• Annual changes were most pronounced in 2023 — Free Cash Flow sank 219.02% — and 2026, when it soared 1827.56%.
• Eli Lilly's Free Cash Flow stood at $1.2 billion in 2022, then slumped by 219.02% to -$1.4 billion in 2023, then surged by 170.69% to $977.7 million in 2024, then plunged by 30.66% to $677.9 million in 2025, then jumped by 343.58% to $3.0 billion in 2026.
• The last three Free Cash Flow figures came in at $3.0 billion (Q1 2026), $677.9 million (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.